MUMBAI: In a fresh case of confrontation between generic pharma industry ... of Indian Patent 209534 which not only discloses but also claims Vildagliptin”, ... At least 18 companies were restrained by Novartis last year in Gujarat ...
Read more: Natco challenges Novartis; claims right to manufacture diabetes drug